Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: Results of a phase I clinical trial in malignant mesothelioma

Human Gene Therapy

Volumn 9, Issue 7, 1998, Pages 1083-1092

  Sterman, Daniel H ^a   Treat, Joseph ^a   Litzky, Leslie A ^a   Amin, Kunjlata M ^a   Coonrod, Laura ^a   Molnar Kimber, Katherine ^a   Recio, Adri ^a   Knox, Linda ^a   Wilson, James M ^a   Albelda, Steven M ^a   Kaiser, Larry R ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b 3400 Spruce Street ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; MESSENGER RNA; THYMIDINE KINASE;

ADENOVIRUS; ADULT; AGED; ANEMIA; ARTICLE; BULLOUS SKIN DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENHANCER REGION; EXPRESSION VECTOR; FEMALE; FEVER; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MALE; MALIGNANT MESOTHELIOMA; PHASE 1 CLINICAL TRIAL; PLEURA BIOPSY; POLYMERASE CHAIN REACTION; PROMOTER REGION; ROUS SARCOMA ONCOVIRUS; VIRUS RECOMBINANT;

ADENOVIRIDAE; HERPES; ONCOVIRINAE; ROUS SARCOMA VIRUS; SIMPLEXVIRUS;

EID: 17344365922     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.7-1083     Document Type: Article

References (17)

1. AISNER, J. (1995). Current approach to malignant mesothelioma of the pleura. Chest 107, 332S-344S.
2. ANTMAN, K.H. (1993). Natural history and epidemiology of malignant mesothelioma. Chest 103, 373S-376S.
3. BÉNARD, F., STERMAN, D.H., SMITH, R.J., KAISER, L.R., ALBELDA, S.M., and ALAVI, A. (1998). Metabolic imaging of malignant pleural mesothelioma with fluorine-18-deoxyglucose positron emission tomography. Chest (accepted for publication).
4. CARUSO, M., PANIS, Y., GAGANDEEP, S., HOUSSIN, D., SALZMANN, J.-L., and KLATZMANN, D. (1993). Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. U.S.A. 90, 7024-7028.
5. CHEN, S.-H., SHINE, H.D., GOODMAN, J.C., GROSSMAN, R.G., and WOO, S.L.C. (1994). Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus mediated gene transfer in vivo. Proc. Natl. Acad. Sci. U.S.A. 91, 3054-3057.
6. CRYSTAL, R.G. (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science. 270, 404-410.
7. CRYSTAL, R.G., MCELVANEY, N.G., ROSENFELD, M.A., CHU, C., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42-51.
8. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLD-FIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
9. ELSHAMI, A.A., SAAVEDRA, A., ZHANG, H.B., KUCHARCZUK, J.C., SPRAY, D.C., FISHMAN, G.I., KAISER, L.R., and ALBELDA, S.M. (1996a). Gap junctions play a role in the "bystander effect" of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther. 3, 85-92.
10. ELSHAMI, A.A., KUCHARCZUK, J., ZHANG, H., SMYTHE, W.R., HUANG, H.C., AMIN, K., LITZKY, L.A., KAISER, L.R., and ALBELDA, S.M. (1996b). Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the HSVthymidine kinase gene. Hum. Gene Ther. 7, 141-148.
11. ELSHAMI, A.A., COOK, J.W., CHOI, H., PARK, J.Y., COONROD, L., AMIN, K.M., WILSON, J.M., KAISER, L.R., and ALBELDA, S.M. (1997). The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivo. Can. Gene Ther. 4, 213-221.
12. ENGLEHARDT, J.F., ZEPEDA, M., COHN, J.A., YANKASKAS, J.R., and WILSON, J.M. (1994). Expression of the cystic fibrosis gene in adult human lung. J. Clin. Invest. 93, 737-749.
13. FREEMAN, S.M., ABBOUD, C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L., and ABRAHAM, G.N. (1993). The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
14. FREEMAN, S.M., RAMESH, R., and MAROGI, A.J. (1997). Immune system in suicide gene therapy. Lancet 349, 2-3.
15. GOLDMAN, M.J., LITZKY, L.A., ENGLEHARDT, J.F., and WILSON, J.M. (1995). Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: A preclinical toxicology study. Hum. Gene Ther. 6, 839-851.
16. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., and SMITH, A.E. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.
17. ZABNER, J., RAMSEY, B.W., MEEKER, D.P., AITKEN, M.L., BALFOUR, R.P., GIBSON, R.L., LAUNSPACH, J., MOSCICKI, R.A., RICHARDS, S.M., STANDAERT, T.A., WILLIAMS-WARREN, J., WADSWORTH, S.C., SMITH, A.E., and WELSH, M.J. (1996). Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J. Clin. Invest. 97, 1504-1511.